Kirsten L. Gruis

Insider Reports History

Location
Minneapolis, MN
Signature
/s/ Amy E. Culbert, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kirsten L. Gruis:

Company Role Class Num Shares Value Price $ Report Date Ownership
DiaMedica Therapeutics Inc. Chief Medical Officer Stock Option (right to buy) 67,000 01 Jun 2023 Direct
DiaMedica Therapeutics Inc. Chief Medical Officer Voting Common Shares, no par value per share 0 $2.80 01 Jun 2023 Direct

Insider Reports Filed by Kirsten L. Gruis

Symbol Company Period Transactions Value $ Form Type Role Filing Time
DMAC DiaMedica Therapeutics Inc. 01 Jun 2023 1 $0 4 Chief Medical Officer 02 Jun 2023, 16:55
DMAC DiaMedica Therapeutics Inc. 03 Jan 2022 1 $0 4 Chief Medical Officer 05 Jan 2022, 15:57
DMAC DiaMedica Therapeutics Inc. 03 Jan 2022 0 $0 3 Chief Medical Officer 05 Jan 2022, 15:48